logo
15:44 Jan 20

Lasa Supergenerics Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
9.04
-0.17 (-1.85%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Lasa Supergenerics Ltd. Financials

Lasa Supergenerics Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
9.04
-0.17 (-1.85%)
15:44 Jan 20
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

28/100
Expensive Valuation

Technical

28/100
Technically Bearish

Strength

5

Weakness

8

Opportunity

0

Threats

0

-17.62 %

ROE %

-14.53 %

ROA %

-7.22

EPS

16.71

BVPS

0.00 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
137.13 129.57 104.34 142.45 95.29
Operating Expenses +
121.49 136.16 102.17 136.18 95.57
Raw Material
94.46 110.12 79.28 108.1 75.5
Increase Decrease in Cost
-3.17 -4.01 -4.06 -1.91 -1.45
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
9.93 7.37 6.34 6.11 4.86
Miscellaneous Expenses
32.77 22.68 20.61 23.88 16.66
Operating Profit
15.64 -6.59 2.17 6.27 -0.28
Other Income
0.06 1.8 0.1 5.01 2.67
Depreciation
14 13.42 10.67 12.3 9.84
Interest
0.04 4.16 1.93 2.69 0.73
Profit before tax and exceptio..
1.65 -22.37 -10.34 -3.71 -8.18
Exceptional Items
-7.86 -19.9 -8.77 -15.67 -36.23
PBT
-6.21 -42.27 -19.11 -19.38 28.05
Provision for Taxation
-0.84 -3.64 2.62 -4.63 -8.26
Net Profit
-5.37 -38.62 -21.73 -14.76 -36.17
NET Profit after MI
0 0 0 0 0
EPS
-1.3 -7.71 -4.34 -2.95 -7.22
Operating Profit Margin (%)
11.41 -5.09 2.08 4.4 -0.29
Net Profit Margin (%)
-3.92 -29.81 -20.83 -10.36 -37.96

Lasa Supergenerics Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: